PTX 0.00% 4.5¢ prescient therapeutics limited

Ann: PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 16,462 Posts.
    lightbulb Created with Sketch. 774
    17 out of 32 patients had stable disease (53%) in AML trial , compelling signs of efficacy. Price should be well over 10c imo based on this one trial alone. The other trials should value it another 10c.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.